Moderna Stocks Rise on Hopes of Omicron Booster Shots
Stocks of Moderna Inc. elevated in Monday late trading after it anticipated to roll out a reformulated vaccine against the Omicron variant by early 2022. Correspondingly, the biotechnology company edged